Ispire to Participate in the Benzinga Cannabis Capital Conference in Chicago on Tuesday, June 10, 2025
- FDA Acceptance Review letter received for IKE Tech's blockchain-enabled age-gating system PMTA
- Strategic positioning as an ancillary cannabis company avoiding direct plant-touching regulatory burdens
- None.
Conference Attendance Follows Historic, First-Ever FDA Acceptance Review of a Standalone, Blockchain-Enabled Age-Gating System
Dennis Lider, SVP of Cannabis, will join the panel titled "The Hidden Winners in Cannabis: Profitable Businesses Without the Red Tape" on Tuesday, June 10, 2025, from 11:00 am to 11:30 am CDT on the Main Stage - Floor 5 (Chicago Ballroom ABCD). The panel will explore how ancillary cannabis companies—including packaging, cultivation solutions, and vaporization hardware—are thriving without the burdens of direct plant-touching operations. Other featured panelists include Gary Santo of Rx Green Technologies, Bryan Gerber of HARA Supply, and Jack Grover of Grove Bags powered by TerpLoc. The session will be moderated by Laurie Parfitt of LKP Impact Consulting.
This announcement follows Ispire's recent disclosure that IKE Tech, a joint venture where Ispire is a founding partner, received an Acceptance Review letter from the FDA – confirming that its PMTA meets regulatory requirements to be accepted, and moves the application into the FDA's filing review phase.
For more information or to schedule a one-on-one meeting with Ispire's management, please contact your Benzinga representative or Ispire Investor Relations at ir@getispire.com.
About IKE Tech LLC
IKE Tech LLC is a joint venture comprised of three leading technology and research companies -- Ispire Technology Inc, Touch Point Worldwide Inc. d/b/a Berify, and Chemular Inc. -- dedicated to revolutionizing Identity and Age Verification (IAV) technology solutions. Recognizing the absence of a universal point-of-sale IAV solution and recognition of the need for one, these companies joined forces to create a unique IAV technology component. IKE's mission is to set the gold standard for IAV by (i) permitting access to electronic nicotine delivery systems by authorized adult users while (ii) preventing underage access through a "plug and play" component compatible across different devices and platforms.
About Ispire Technology Inc.
Ispire is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company's operating subsidiaries own or license more than 400 patents worldwide. Ispire's branded e-cigarette products are marketed under the Aspire name and are sold worldwide (except in the
Forward Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended ("Securities Act") as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company's future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as "believe," "expect," "may," "will," "should," "would," "could," "seek," "intend," "plan," "goal," "project," "estimate," "anticipate," "strategy," "future," "likely" or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company's strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company's actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: the Company's ability to collect its accounts receivable in a timely manner, the Company's business strategies, the ability of the Company to market to the Ispire ONE™, Ispire ONE's success of meeting its goals, the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of their products on the markets; the Ispire ONE™ proving to be safe, and the risk and uncertainties described in "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Cautionary Note on Forward-Looking Statements" and the additional risk described in Ispire's Annual Report on Form 10-K for the year ended June 30, 2023 and any subsequent filings which Ispire makes with the
IR Contacts:
For more information, kindly contact:
Investor Relations
Sherry Zheng
718.213.7386
ir@ispiretechnology.com
KCSA Strategic Communications
Phil Carlson
212.896.1233
ispire@kcsa.com
PR Contact:
Ellen Mellody
570.209.2947
ispire@kcsa.com
###
View original content:https://www.prnewswire.com/news-releases/ispire-to-participate-in-the-benzinga-cannabis-capital-conference-in-chicago-on-tuesday-june-10-2025-302474708.html
SOURCE Ispire Technology Inc.
FAQ
What is Ispire Technology's (ISPR) role in the Benzinga Cannabis Capital Conference 2025?
What recent regulatory milestone did Ispire (ISPR) achieve with the FDA?
Who are the other panelists joining Ispire (ISPR) at the Benzinga Cannabis Conference?
What is Ispire Technology's (ISPR) business focus in the cannabis industry?
When and where is the Benzinga Cannabis Capital Conference 2025 taking place?
